36.78
Schlusskurs vom Vortag:
$36.23
Offen:
$36.59
24-Stunden-Volumen:
438.30K
Relative Volume:
0.47
Marktkapitalisierung:
$15.82B
Einnahmen:
$5.81B
Nettoeinkommen (Verlust:
$412.00M
KGV:
39.13
EPS:
0.94
Netto-Cashflow:
-
1W Leistung:
+3.61%
1M Leistung:
+21.47%
6M Leistung:
+43.06%
1J Leistung:
+24.21%
Smith Nephew Plc Adr Stock (SNN) Company Profile
Firmenname
Smith Nephew Plc Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie SNN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
SNN
Smith Nephew Plc Adr
|
36.78 | 15.82B | 5.81B | 412.00M | 0 | 0.94 |
![]()
ABT
Abbott Laboratories
|
129.40 | 228.03B | 43.11B | 13.94B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
102.50 | 152.09B | 18.49B | 2.50B | 3.49B | 1.68 |
![]()
SYK
Stryker Corp
|
378.95 | 143.98B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
MDT
Medtronic Plc
|
92.91 | 117.98B | 33.54B | 4.69B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
77.68 | 45.17B | 5.69B | 1.41B | 577.90M | 6.95 |
Smith Nephew Plc Adr Stock (SNN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-04-25 | Herabstufung | HSBC Securities | Buy → Hold |
2025-03-12 | Herabstufung | UBS | Buy → Neutral |
2024-11-06 | Herabstufung | Berenberg | Buy → Hold |
2024-11-01 | Herabstufung | Deutsche Bank | Buy → Hold |
2024-07-24 | Eingeleitet | Deutsche Bank | Buy |
2024-06-05 | Hochstufung | UBS | Neutral → Buy |
2023-11-28 | Hochstufung | Barclays | Underweight → Equal Weight |
2023-11-03 | Hochstufung | JP Morgan | Neutral → Overweight |
2023-10-31 | Hochstufung | HSBC Securities | Hold → Buy |
2023-10-13 | Eingeleitet | Stifel | Hold |
2023-08-08 | Hochstufung | UBS | Sell → Neutral |
2023-04-27 | Herabstufung | HSBC Securities | Buy → Hold |
2023-04-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2022-12-12 | Eingeleitet | Citigroup | Buy |
2022-11-28 | Herabstufung | UBS | Neutral → Sell |
2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
2022-07-28 | Herabstufung | Canaccord Genuity | Buy → Hold |
2022-03-16 | Eingeleitet | RBC Capital Mkts | Outperform |
2022-03-15 | Eingeleitet | RBC Capital Mkts | Outperform |
2022-03-04 | Hochstufung | Redburn | Sell → Neutral |
2021-06-09 | Hochstufung | Credit Suisse | Neutral → Outperform |
2020-12-18 | Hochstufung | Bernstein | Mkt Perform → Outperform |
2020-12-01 | Eingeleitet | Barclays | Overweight |
2020-07-29 | Hochstufung | BofA Securities | Neutral → Buy |
2020-06-04 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2020-04-14 | Herabstufung | Citigroup | Buy → Neutral |
2019-11-21 | Eingeleitet | Citigroup | Buy |
2019-11-12 | Eingeleitet | Bernstein | Outperform |
2019-07-23 | Hochstufung | Berenberg | Hold → Buy |
2019-02-08 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
2019-01-02 | Herabstufung | JP Morgan | Overweight → Neutral |
2018-12-10 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2018-11-01 | Bestätigt | Canaccord Genuity | Buy |
2018-01-25 | Hochstufung | JP Morgan | Neutral → Overweight |
2017-12-11 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2017-10-11 | Eingeleitet | Canaccord Genuity | Buy |
2017-02-27 | Herabstufung | Goldman | Buy → Neutral |
2017-01-19 | Eingeleitet | HSBC Securities | Hold |
2016-12-08 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2016-10-06 | Herabstufung | Berenberg | Buy → Hold |
2016-02-26 | Eingeleitet | Cantor Fitzgerald | Hold |
Alle ansehen
Smith Nephew Plc Adr Aktie (SNN) Neueste Nachrichten
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
Smith & Nephew Earnings: The Turnaround Started Three Years Ago and Now Bears Fruit - Morningstar
Smith & Nephew's Turnaround Pushes Profitability Higher - Morningstar
Smith & Nephew plc ADR: Rising 11.43% from 52-Week Low, Can the Stock Stay Afloat? - investchronicle.com
Smith & Nephew SNATS, Inc. (SNN) Stock Forecasts - Yahoo Finance
What Are Expectations For Smith & Nephew plc ADR (NYSE: SNN) In The Short Term? - stocksregister.com
Upwork Inc (NASDAQ: UPWK) Is Down -0.17% – Is It A Buying Opportunity? - stocksregister.com
Advanced Wound Care Market to Hit $19.32 Billion by 2030 – What’s Fueling the Surge? | MarketsandMarkets™. - GlobeNewswire Inc.
Haleon PLC Sponsored ADR (NYSE:HLN) Shares Sold by Bank of New York Mellon Corp - Defense World
SNN’s 2023 Market Dance: Up 12.53% – Time to Invest? - investchronicle.com
Bessemer Group Inc. Purchases 1,701 Shares of Smith & Nephew SNATS, Inc. (NYSE:SNN) - Defense World
Smith & Nephew (LON:SN) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World
Smith & Nephew appoints new Non-Executive Director - Investing.com
Study shows patients treated with Smith+Nephew’s CARTIHEAL™ AGILI-C™ Cartilage Repair Implant have an 87% lower relative risk of Total Knee Arthroplasty or Osteotomy at 4 years¹ - The Globe and Mail
Shell Plc Declares Q1 2025 Dividend - DirectorsTalk Interviews
Smith & Nephew plc ADR [SNN] Investment Appeal on the Rise - knoxdaily.com
TRI (Thomson-Reuters Corp) may reap gains as insiders became active recently - knoxdaily.com
Glaukos Corporation (GKOS) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
Smith+Nephew reports solid Q1 2025 growth - Investing.com
Earnings call transcript: Smith & Nephew Q1 2025 sees steady growth and innovation - Investing.com
AN Stock Sees Surge of Approximately 3.05% in Last Five Days - knoxdaily.com
Smith+Nephew schedules Q1 2025 trading report release - Investing.com
UBS cuts Smith & Nephew stock rating to Neutral, sets GBP1.25 target - Investing.com
Smith & Nephew releases 2024 annual financial report By Investing.com - Investing.com UK
FTSE 100 up; Smith & Nephew surges; BAE gets UK defence boost - Investing.com UK
Smith+Nephew to announce 2024 full year results February 25 - Investing.com
Smith+Nephew appoints new Non-Executive Director - Investing.com
Rio Tinto Plc 2025 Dividend Schedule And Key Event Dates - DirectorsTalk Interviews
World adrs in Stocks Markets - richtv.io
Smith & Nephew Sees Challenges in China Market - Morningstar
The Best Healthcare Stocks to Buy - Morningstar
China Surgical Navigation Systems Market Size & Outlook, 2030 - Grand View Research
Europe First Aid Market Size & Outlook, 2023-2030 - Grand View Research
Healthcare Sector - Morningstar
7 Robotic Surgery Stocks to Buy for the Future of Healthcare - Yahoo Finance
Weekly Upgrades and Downgrades - Yahoo Finance
Validea Detailed Fundamental AnalysisSNN - Nasdaq
Zimmer Biomet Holdings Inc. stock outperforms market on strong trading day - MarketWatch
Zimmer Biomet Holdings Inc. stock falls Thursday, underperforms market - MarketWatch
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Zimmer Biomet Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
Zimmer Biomet Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Zimmer Biomet Holdings Inc. stock rises Monday, outperforms market - MarketWatch
Zimmer Biomet Holdings Inc. stock rises Friday, still underperforms market - MarketWatch
Zimmer Biomet Holdings Inc. stock falls Tuesday, underperforms market - MarketWatch
Zimmer Biomet Holdings Inc. stock rises Thursday, still underperforms market - MarketWatch
Zimmer Biomet Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
Zimmer Biomet Holdings Inc. stock rises Tuesday, outperforms market - MarketWatch
Finanzdaten der Smith Nephew Plc Adr-Aktie (SNN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):